HEPATOSPLENIC T-CELL LYMPHOMA
Clinical trials for HEPATOSPLENIC T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATOSPLENIC T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for HEPATOSPLENIC T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin d boosts cancer survival in new trial
Disease control OngoingThis study looks at whether giving vitamin D supplements to cancer patients who have low vitamin D levels can improve their survival and delay the need for treatment. About 565 adults with certain types of lymphoma or leukemia are taking part. Researchers are comparing those who …
Matched conditions: HEPATOSPLENIC T-CELL LYMPHOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New combo therapy shows promise against aggressive t-cell lymphoma
Disease control OngoingThis study tested a combination of a targeted drug (brentuximab vedotin) and chemotherapy in 48 people with a rare type of blood cancer called CD30-positive peripheral T-cell lymphoma. The goal was to see how well the treatment shrinks tumors and what side effects occur. Particip…
Matched conditions: HEPATOSPLENIC T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Engineered immune cells take aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-stage trial tests a new treatment called WU-CART-007 for people with certain blood cancers (like acute myeloid leukemia and T-cell lymphoma) that have not responded to standard therapy. The treatment uses donor immune cells that are specially modified to target and kil…
Matched conditions: HEPATOSPLENIC T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 08, 2026 12:02 UTC